Sangeetha Iyer, Joshua D. Mast, Hillary Tsang, Tamy P. Rodriguez, Nina DiPrimio, Madeleine Prangley, . . . Ethan O. Perlstein. (2019). Drug screens of NGLY1 deficiency in worm and fly models reveal catecholamine, NRF2 and anti-inflammatory-pathway activation as potential clinical approaches. The Company of Biologists.
Chicago Style (17th ed.) CitationSangeetha Iyer, Joshua D. Mast, Hillary Tsang, Tamy P. Rodriguez, Nina DiPrimio, Madeleine Prangley, Feba S. Sam, Zachary Parton, and Ethan O. Perlstein. Drug Screens of NGLY1 Deficiency in Worm and Fly Models Reveal Catecholamine, NRF2 and Anti-inflammatory-pathway Activation as Potential Clinical Approaches. The Company of Biologists, 2019.
MLA (9th ed.) CitationSangeetha Iyer, et al. Drug Screens of NGLY1 Deficiency in Worm and Fly Models Reveal Catecholamine, NRF2 and Anti-inflammatory-pathway Activation as Potential Clinical Approaches. The Company of Biologists, 2019.